{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:04:29Z","timestamp":1780722269920,"version":"3.54.1"},"reference-count":60,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Lung cancer remains the most prevalent malignancy and the leading cause of cancer-related mortality worldwide, highlighting the need for novel therapeutic strategies. \u03b2-Hydroxybutyrate (BHB), the primary circulating ketone body, has shown antitumor activity in other cancers, but its role in non-small cell lung cancer (NSCLC) is not well defined. This study investigated the anticancer and anti-angiogenic effects of BHB alone and in combination with Gemcitabine using in vitro and in vivo approaches. In A549 (adenocarcinoma) and LNM35 (large-cell carcinoma) NSCLC cells, BHB significantly reduced cell number and colony growth in a concentration-dependent manner, with LNM35 cells exhibiting greater sensitivity. Migration of both A549 and LNM35 cells was also markedly inhibited. In endothelial Telo-HAEC cells, BHB exhibited no cytotoxicity but significantly inhibited migration, tube formation, and VEGF-induced spheroid sprouting, indicating anti-angiogenic activity. Combination studies showed that BHB enhanced Gemcitabine-mediated suppression of NSCLC cell number and colony growth, consistent with an additive to synergistic effect. In the chick embryo chorioallantoic membrane model, BHB and Gemcitabine reduced tumor growth individually, while their combination further decreased tumor weight, particularly in LNM35 xenografts, without observable toxicity. These findings provide preclinical evidence that BHB enhances Gemcitabine antitumor activity against NSCLC and reveals its in vitro anti-angiogenic effects.<\/jats:p>","DOI":"10.3390\/ijms27115103","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:23:21Z","timestamp":1780622601000},"page":"5103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b2-Hydroxybutyrate Inhibits Angiogenesis, Suppresses Non-Small Cell Lung Cancer Growth, and Enhances Gemcitabine Antitumor Activity"],"prefix":"10.3390","volume":"27","author":[{"given":"Yomna","family":"Labanie","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud","family":"Arafat","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrazad","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Mudhafar","family":"Al-Azawi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Attoub","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates"},{"name":"ASPIRE Precision Medicine Research Institute Abu Dhabi, United Arab Emirates University, Al-Ain 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref_1","unstructured":"(2024, February 28). WHO Global Cancer Burden Growing. Available online: https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"n2363","DOI":"10.1136\/bmj.n2363","article-title":"Advances in systemic therapy for non-small cell lung cancer","volume":"375","author":"Miller","year":"2021","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.17992\/lbl.2022.01.671","article-title":"Advances in lung cancer diagnosis and treatment\u2014A review","volume":"108","author":"Jonsson","year":"2022","journal-title":"Laeknabladid"},{"key":"ref_4","first-page":"863","article-title":"Delay in diagnosis of lung cancer in general practice","volume":"56","author":"Bjerager","year":"2006","journal-title":"Br. J. Gen. Pract."},{"key":"ref_5","unstructured":"(2024, May 21). \u2018Cancer of the Lung and Bronchus\u2014Cancer Stat Facts\u2019, SEER, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html."},{"key":"ref_6","unstructured":"Basumallik, N., and Agarwal, M. (2023, September 27). Small Cell Lung Cancer, StatPearls, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482458\/."},{"key":"ref_7","unstructured":"Clark, S.B., and Alsubait, S. (2023, September 27). Non\u2013Small Cell Lung Cancer, StatPearls, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562307\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer","volume":"13","author":"Devine","year":"2020","journal-title":"Surg. Pathol. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4143\/crt.2022.078","article-title":"Challenges in the Use of Targeted Therapies in Non\u2013Small Cell Lung Cancer","volume":"54","author":"Uprety","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cllc.2020.02.024","article-title":"The Story of Angiogenesis Inhibitors in Non-small-cell Lung Cancer: The Past, Present, and Future","volume":"21","author":"Shukla","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","article-title":"Ketogenic diet in the treatment of cancer\u2014Where do we stand?","volume":"33","author":"Weber","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18632\/aging.101382","article-title":"Ketogenic diet in cancer therapy","volume":"10","author":"Weber","year":"2018","journal-title":"Aging"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dilliraj, L.N., Schiuma, G., Lara, D., Strazzabosco, G., Clement, J., Giovannini, P., Trapella, C., Narducci, M., and Rizzo, R. (2022). The Evolution of Ketosis: Potential Impact on Clinical Conditions. Nutrients, 14.","DOI":"10.3390\/nu14173613"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u03b2-Hydroxybutyrate","volume":"37","author":"Newman","year":"2017","journal-title":"Annu. Rev. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5698\/1535-7597-14.6.355","article-title":"The New Ketone Alphabet Soup: BHB, HCA, and HDAC","volume":"14","author":"Hartman","year":"2014","journal-title":"Epilepsy Curr."},{"key":"ref_16","first-page":"97","article-title":"\u03b2-hydroxybutyrate does not influence viability and clonogenicity of A549 lung cancer cells","volume":"14","author":"Malcanli","year":"2023","journal-title":"Acibadem Univ. Saglik Bilim. Derg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1111\/cas.14168","article-title":"Apatinib induces 3-hydroxybutyric acid production in the liver of mice by peroxisome proliferator-activated receptor \u03b1 activation to aid its antitumor effect","volume":"110","author":"Feng","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1356508","DOI":"10.1155\/2019\/1356508","article-title":"Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis","volume":"2019","author":"Tahtamouni","year":"2019","journal-title":"Anal. Cell. Pathol."},{"key":"ref_19","first-page":"67","article-title":"Chapter 3\u2014Antiangiogenic agents in the treatment of colorectal, gastric, and gastroesophageal junction adenocarcinoma","volume":"Volume 18","author":"Morbidelli","year":"2022","journal-title":"Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in Cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_21","unstructured":"Mokhtari, R.B., Homayouni, T.S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., and Yeger, H. (2024, June 11). Combination Therapy in Combating Cancer\u2014PMC, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5514969\/."},{"key":"ref_22","unstructured":"(2024, June 12). NCI Gemcitabine Hydrochloride\u2014NCI, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/gemcitabinehydrochloride."},{"key":"ref_23","first-page":"37S","article-title":"Ketogenic Diets and Cancer: Emerging Evidence","volume":"34","year":"2017","journal-title":"Fed. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_25","unstructured":"(2024, June 03). Hallmarks of Cancer: The Next Generation: Cell. Available online: https:\/\/www.cell.com\/cell\/fulltext\/S0092-8674(11)00127-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867411001279%3Fshowall%3Dtrue."},{"key":"ref_26","unstructured":"Masood, W., Annamaraju, P., Khan Suheb, M.Z., and Uppaluri, K.R. (2024, June 04). Ketogenic Diet, StatPearls, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499830\/."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tamraz, M., Al Ghossaini, N., and Temraz, S. (2023). The Ketogenic Diet in Colorectal Cancer: A Means to an End. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043683"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-022-04649-6","article-title":"\u03b2-Hydroxybutyrate suppresses colorectal cancer","volume":"605","author":"Wong","year":"2022","journal-title":"Nature"},{"key":"ref_29","first-page":"e00038","article-title":"\u03b2-hydroxybutyrate inhibits cellular proliferation, EMT, stemness, migration, and invasion in glioma cells","volume":"2","author":"Yang","year":"2023","journal-title":"Precis. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12935-024-03277-6","article-title":"\u03b2-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through \u03b2-hydroxybutyrylation of indoleacetamide-N-methyltransferase","volume":"24","author":"Zhang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e8805868","DOI":"10.1155\/2024\/8805868","article-title":"Exploring the Therapeutic Potential of \u03b2-Hydroxybutyrate (BHB) in Clear Cell Renal Cell Carcinoma: A Journey into Fat Browning, Autophagy, and Tumor Slimming","volume":"2024","author":"Rezaei","year":"2024","journal-title":"Int. J. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-022-10459-9","article-title":"HMGCL-induced \u03b2-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility","volume":"17","author":"Cui","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40170-017-0166-z","article-title":"The action of \u03b2-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: Evidence of a \u03b2-hydroxybutyrate paradox","volume":"5","author":"Rodrigues","year":"2017","journal-title":"Cancer Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.31557\/APJCP.2018.19.11.3287","article-title":"Beta-Hydroxybutyrate Promotes Proliferation, Migration and Stemness in a Subpopulation of 5FU Treated SW480 Cells: Evidence for Metabolic Plasticity in Colon Cancer","volume":"19","author":"Shakery","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"EMBJ2021110466","DOI":"10.15252\/embj.2021110466","article-title":"Costa Ketogenic HMG-CoA lyase and its product \u03b2-hydroxybutyrate promote pancreatic cancer progression","volume":"41","author":"Gouirand","year":"2022","journal-title":"EMBO"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e30212","DOI":"10.1016\/j.heliyon.2024.e30212","article-title":"The ketone body \u03b2-Hydroxybutyrate as a fuel source of chondrosarcoma cells","volume":"10","year":"2024","journal-title":"Heliyon"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11033-024-09501-w","article-title":"Beta hydroxybutyrate induces lung cancer cell death, mitochondrial impairment and oxidative stress in a long term glucose-restricted condition","volume":"51","author":"Shirian","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/ol.2020.12326","article-title":"\u03b2-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells","volume":"21","author":"Maldonado","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41416-020-01149-0","article-title":"Mutational drivers of cancer cell migration and invasion","volume":"124","author":"Novikov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11033-024-09355-2","article-title":"Improved therapy for clear cell renal cell carcinoma: Beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance","volume":"51","author":"Mohammadipoor","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1634\/theoncologist.4-3-241","article-title":"Gemcitabine: Single-Agent and Combination Therapy in Non-Small Cell Lung Cancer","volume":"4","author":"Sandler","year":"1999","journal-title":"Oncologist"},{"key":"ref_43","first-page":"209","article-title":"Gemcitabine for the treatment of advanced nonsmall cell lung cancer","volume":"2","author":"Toschi","year":"2009","journal-title":"OncoTargets Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1158\/2767-9764.CRC-22-0256","article-title":"A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice","volume":"2","author":"Cortez","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cortez, N.E., Pathak, S., Rodriguez Lanzi, C., Hong, B.V., Crone, R., Sule, R., Wang, F., Chen, S., Gomes, A.V., and Baar, K. (2023). A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202306.0482.v1"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0148607115595221","article-title":"Intravenous \u03c9-3 Fatty Acids Plus Gemcitabine","volume":"41","author":"Arshad","year":"2017","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/excr.1998.4172","article-title":"Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism","volume":"243","author":"Foster","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_48","first-page":"2535","article-title":"Establishment and Characterization of a Human Lung Cancer Cell Line NCI-H460-LNM35 with Consistent Lymphogenous Metastasis via Both Subcutaneous and Orthotopic Propagation","volume":"60","author":"Kozaki","year":"2000","journal-title":"Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Cunha, A., Rocha, A.C., Barbosa, F., Bai\u00e3o, A., Silva, P., Sarmento, B., and Queir\u00f3s, O. (2022). Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102021"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13046-019-1407-5","article-title":"Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer","volume":"38","author":"Kim","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Al-Azawi, A., Sulaiman, S., Arafat, K., Yasin, J., Nemmar, A., and Attoub, S. (2021). Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212553"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/0976-500X.81895","article-title":"Toxicological screening","volume":"2","author":"Parasuraman","year":"2011","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2042098620915057","DOI":"10.1177\/2042098620915057","article-title":"Communication on drug safety-related matters to patients: Is it even more significant in this digital era?","volume":"11","author":"Jose","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","article-title":"Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_55","first-page":"154","article-title":"The Effects of Exogenous Beta-Hydroxybutyrate Supplementation on Metrics of Safety and Health","volume":"9","author":"Stefan","year":"2020","journal-title":"Int. J. Nutr. Food Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Stefan, M., Sharp, M., Gheith, R., Lowery, R., and Wilson, J. (2021). The Effect of Exogenous Beta-Hydroxybutyrate Salt Supplementation on Metrics of Safety and Health in Adolescents. Nutrients, 13.","DOI":"10.3390\/nu13030854"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12491","DOI":"10.1038\/s41598-020-69500-2","article-title":"\u03b2-hydroxybutyrate and hydroxycarboxylic acid receptor 2 agonists activate the AKT, ERK and AMPK pathways, which are involved in bovine neutrophil chemotaxis","volume":"10","author":"Carretta","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pali, D.V., Kim, S., Mantik, K.E.K., Lee, J.-B., So, C.-Y., Moon, S., Park, D.-H., Kwak, H.-B., and Kang, J.-H. (2025). Unraveling the Translational Relevance of \u03b2-Hydroxybutyrate as an Intermediate Metabolite and Signaling Molecule. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157362"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10557-021-07267-y","article-title":"\u03b2-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1\u03b1-Dependent Glycolysis in Cardiomyocytes\u2014Adding Fuel to the Fire?","volume":"36","author":"Ma","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"Georgiadou","year":"2013","journal-title":"Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:44:44Z","timestamp":1780721084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27115103"],"URL":"https:\/\/doi.org\/10.3390\/ijms27115103","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}